699 related articles for article (PubMed ID: 26900300)
1. CD24 genetic variants contribute to overall survival in patients with gastric cancer.
Jia ZF; Wang LZ; Cao XY; Wang C; Cao DH; Wu X; You LL; Jin MS; Wang YP; Zhou BS; Jiang J
World J Gastroenterol; 2016 Feb; 22(7):2373-82. PubMed ID: 26900300
[TBL] [Abstract][Full Text] [Related]
2. High expression of CD11c indicates favorable prognosis in patients with gastric cancer.
Wang Y; Xu B; Hu WW; Chen LJ; Wu CP; Lu BF; Shen YP; Jiang JT
World J Gastroenterol; 2015 Aug; 21(31):9403-12. PubMed ID: 26309367
[TBL] [Abstract][Full Text] [Related]
3. Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.
Xue MH; Li GY; Wu XJ; Zhang CX; Zhang CF; Zhu KX
Int J Clin Exp Pathol; 2015; 8(5):5563-9. PubMed ID: 26191265
[TBL] [Abstract][Full Text] [Related]
4. Association of
Wang XQ; Terry PD; Li Y; Zhang Y; Kou WJ; Wang MX
World J Gastroenterol; 2019 Sep; 25(34):5152-5161. PubMed ID: 31558863
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy Effectiveness and Prognosis of Gastric Cancer Influenced by PTPN11 Polymorphisms.
Zhuo C; Shao M; Chen C; Lin C; Jiang D; Chen G; Tian H; Wang L; Li J; Lin X
Cell Physiol Biochem; 2016; 39(4):1537-52. PubMed ID: 27614952
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation rs10484761 on 6p21.1 derived from a genome-wide association study is associated with gastric cancer survival in a Chinese population.
Kang M; Ding X; Xu M; Zhu H; Liu S; Wang M; Wu D; Tong N; Gong W; Zhou J; Zhang Z
Gene; 2014 Feb; 536(1):59-64. PubMed ID: 24325909
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms at the microRNA binding-site of the stem cell marker gene CD133 modify susceptibility to and survival of gastric cancer.
Wang Q; Liu H; Xiong H; Liu Z; Wang LE; Qian J; Muddasani R; Lu V; Tan D; Ajani JA; Wei Q
Mol Carcinog; 2015 Jun; 54(6):449-58. PubMed ID: 24302553
[TBL] [Abstract][Full Text] [Related]
8. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer.
Hou L; El-Omar EM; Chen J; Grillo P; Rabkin CS; Baccarelli A; Yeager M; Chanock SJ; Zatonski W; Sobin LH; Lissowska J; Fraumeni JF; Chow WH
Carcinogenesis; 2007 Jan; 28(1):118-23. PubMed ID: 16885196
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of ERCC1 and ERCC2 gene polymorphisms in patients with gastric cancer receiving platinum-based chemotherapy.
Mo J; Luo M; Cui J; Zhou S
Int J Clin Exp Pathol; 2015; 8(11):15065-71. PubMed ID: 26823845
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor receptor 4 Gly388Arg polymorphism in Chinese gastric cancer patients.
Shen YY; Lu YC; Shen DP; Liu YJ; Su XY; Zhu GS; Yin XL; Ni XZ
World J Gastroenterol; 2013 Jul; 19(28):4568-75. PubMed ID: 23901234
[TBL] [Abstract][Full Text] [Related]
13. Relevance of GSTM1, GSTT1, and GSTP1 gene polymorphisms to gastric cancer susceptibility and phenotype.
García-González MA; Quintero E; Bujanda L; Nicolás D; Benito R; Strunk M; Santolaria S; Sopeña F; Badía M; Hijona E; Pérez-Aísa MA; Méndez-Sánchez IM; Thomson C; Carrera P; Piazuelo E; Jiménez P; Espinel J; Campo R; Manzano M; Geijo F; Pellisé M; González-Huix F; Espinós J; Titó L; Zaballa M; Pazo R; Lanas A
Mutagenesis; 2012 Nov; 27(6):771-7. PubMed ID: 22952149
[TBL] [Abstract][Full Text] [Related]
14. Association of heparanase gene (HPSE-1) single nucleotide polymorphisms with gastric cancer.
Yue Z; Song Y; Wang Z; Luo Y; Jiang L; Xing L; Xu H; Zhang X
J Surg Oncol; 2010 Jul; 102(1):68-72. PubMed ID: 20578081
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-16 polymorphisms as new promising biomarkers for risk of gastric cancer.
Kashfi SM; Behboudi Farahbakhsh F; Nazemalhosseini Mojarad E; Mashayekhi K; Azimzadeh P; Romani S; Derakhshani S; Malekpour H; Asadzadeh Aghdaei H; Zali MR
Tumour Biol; 2016 Feb; 37(2):2119-26. PubMed ID: 26346169
[TBL] [Abstract][Full Text] [Related]
16. Single Nucleotide Polymorphism of the Enhancer of Zeste Homolog 2 Gene rs2072408 is Associated with Lymph Node Metastasis and Depth of Primary Tumor Invasion in Gastric Cancer.
Sun B; Lin Y; Wang X; Lan F; Yu Y; Huang Q
Clin Lab; 2016 Nov; 62(11):2099-2105. PubMed ID: 28164661
[TBL] [Abstract][Full Text] [Related]
17. Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer.
Lian PL; Liu Z; Yang GY; Zhao R; Zhang ZY; Chen YG; Zhuang ZN; Xu KS
World J Gastroenterol; 2016 Apr; 22(14):3852-9. PubMed ID: 27076771
[TBL] [Abstract][Full Text] [Related]
18. Association analysis between SNPs in LATS1 and LATS2 and non-cardia gastric cancer.
Ma LC; Tian XY; Gao F; Dong WJ; Dang T; Jia YB
BMC Gastroenterol; 2020 May; 20(1):155. PubMed ID: 32423384
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibility.
Lin Y; Nie Y; Zhao J; Chen X; Ye M; Li Y; Du Y; Cao J; Shen B; Li Y
Carcinogenesis; 2012 Dec; 33(12):2377-83. PubMed ID: 22971574
[TBL] [Abstract][Full Text] [Related]
20. [Association of polymorphism in matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 with genetic susceptibility of gastric cancer].
Lin XD; Chen G; Li C; Zhang LY; Shi Y; Zhou DM; Zheng XW
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Aug; 45(8):711-6. PubMed ID: 22169692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
